IMN clinics

The clinical branch of the Institute of Neurodegenerative Diseases (IMNc) combines patient care (Expert Center for Parkinson’s disease, Dementia Clinic, French Reference Centre for Multiple System Atrophy, Competence Centre for Rare Dementia, Competence Centre for Tourette Syndrome) and clinical research in the fields of neurodegenerative diseases and movement disorders. Our research program builds on three axes. The first research axis investigates the pathophysiology of movement disorders and neurodegenerative diseases, focusing on dystonia, Tourette syndrome, gait, and tremor using both imaging and electrophysiological technics. The second research axis investigates the natural history of neurodegenerative disorders. It aims to determine factors of prognosis, survival, and health-related quality of life and identify potential diagnosis and prognosis biomarkers by taking advantage of several well-characterized prospective clinical cohorts. The third research axis capitalizes upon the long-standing expertise of IMNc investigators in clinical trials. This research axis emphasizes the refinement of clinical assessment tools and the development of diagnosis and prognosis biomarkers. The investigators of the IMNc research team lead or contribute to numerous academic and industry-sponsored multi-center trials. Also, the team focuses on complementary medicine and developing non-pharmacological interventions (mindfulness, psychosocial support, and care by specialized teams).